CD69 and acute lymphoblastic leukemia: Indeed, when used at a dosage corresponding to the amount of IFN-α produced by pDCs [27], IFN-α induced lower TRAIL and CD69 expression levels, lower IFN-γ production and lower lytic activity against ALL cells than with NK cells stimulated with activated pDCs (Figure 1).